The burden of cancer supportive care
|
|
- Wilfred Rose
- 7 years ago
- Views:
Transcription
1 CERGAS The burden of cancer supportive care Rosanna Tarricone, PhD Director CERGAS Bocconi University Milano,
2 Cancer. Epidemiology and economics The burden of cancer supportive care Current evidence: an unexplored issue The way forward and conclusive remarks
3 The burden of Non Communicable Diseases (NCDs) In 2011, 55 million people died worldwide NCDs were responsible for 2/3 of all deaths globally 87% of all deaths were caused by NCDs in high-income countries The 4 main NCDs are cardiovascular diseases, cancers, diabetes and chronic lung diseases Source: WHO, The top 10 leading causes of death, 2013
4 Cancer: epidemiological burden 14.1 million new cancer cases 8.2 million cancer deaths 32.6 million people living with cancer Source: WHO, The top 10 leading causes of death, 2013
5 Cancer: epidemiological burden U.S.A. EU-28 China 45 % of all deaths in 2012 Lung Cancer Breast Cancer Colon Rectal Cancer Prostate Cancer Source: WHO, The top 10 leading causes of death, 2013
6 The economic burden of cancer in EU countries In 2009 the total economic cost of cancer in the EU was more than 126 billion The health-care cost was 51 billion that accounted for 4% of total EU health-care expenditure, of these: Inpatient care costs were estimated to be 28,4 billion, accounting for 56 % of cancer-related health-care costs Drug costs accounted for more than 13,5 billion 27 % of cancer-related health-care costs. However, 60 % of the economic burden of cancer was incurred in non-health-care areas, with almost 43 billion incurred in lost productivity attributable to early death Source: Luengo-Fernandez et al. Economic burden of cancer across the European Union: a population-based cost analysis. The Lancet Oncology 2013;14(12):
7 The economic burden of cancer in EU countries The cost of lung, breast, colorectal, and prostate cancers was 55,3 billion i.e, 44 % of the total economic cost of cancer: 15 % Lung cancer 18,8 billion 12 % Breast cancer 15,0 billion 10 % Colorectal cancer 13,1 billion 7 % Prostate cancer 8,43 billion Source: Luengo-Fernandez et al. Economic burden of cancer across the European Union: a population-based cost analysis. The Lancet Oncology 2013;14(12):
8 The economic burden of cancer (USA) in 2008 In the USA, the cost of cancer was estimated at US$ 202 billion ( 157) US$ 77 billion ( 60) were direct medical costs US$ 125 billion ( 97) were mortality costs. Source: Luengo-Fernandez et al. Economic burden of cancer across the European Union: a population-based cost analysis. The Lancet Oncology 2013;14(12):
9 Too many patients still experience cancer care side effects individual s quality of life dose delays, dose reductions, reduction in dose density and in some cases dose discontinuation increase in hospitalization emergency room visits adoption of a palliative treatment and increase the care giving burden which reduce the effectiveness of chemotherapy that worsen health outcomes. all of which raise the costs for healthcare systems, patients and care givers.
10 Chemotherapy-Induced Diarrhoea: a side effect whose incidence is 50-80% worldwide 54 % Patients suffering from colon rectal cancer developed diarrhoea grade III or IV after the first cycle of chemotherapy 43 % attended the emergency department for symptom control 59 % patients attended an unscheduled visit to the oncology centre 14 % 5 % patients died, 5% of which had uncontrolled diarrhoea Sources: Benson et al., Recommended guidelines for the treatment of cancer treatment-induced diarrhea. J Clin Oncol 2004;22: Gibson & Stringer Chemotherapy-induced diarrhea. Curr Opin Suppot Palliat Care 2009;3:31-5
11 Chemotherapy-Induced Diarrhoea: a side effect whose incidence is 50-80% worldwide 27 % patients having to delay their chemotherapy for 14 days 86 % patients had a median hospitalisation length of 8 days 33 % patients had their chemotherapy reduced by 25% 16 % patients had their chemotherapy changed 4 % patients had their chemotherapy discontinued The total cost per hospitalisation per patient with diarrhoea grade III or IV was estimated to be on average US$ 8,230 Sources: Benson et al., Recommended guidelines for the treatment of cancer treatment-induced diarrhea. J Clin Oncol 2004;22: Gibson & Stringer Chemotherapy-induced diarrhea. Curr Opin Suppot Palliat Care 2009;3:31-5
12 Chemotherapy-Induced Diarrhoea: an avoidable cost CID has shown to bear a relevant proportion of avoidable costs in terms of hospitalisations, unplanned visits, tests, drug consumptions, discontinuation or prolongation of chemotherapy These cost components are likely to be complemented by informal care and productivity losses that have not been investigated in current literature but can further explain an important fraction of CID total burden Furthermore, quality of life - the most important outcome in research in oncology - has not been extensively investigated when CID is at stake Source: Tarricone et al. Chemotherapy induced diarrhea (CID) what do we know about its prevalence, incidence and the impact that it has on costs and quality of life: a systematic literature review. Preliminary findings
13 Cancer Cachexia-Anorexia Syndrome: a side effect that impacts till 80% of advanced cancer patients CACS imposes an additional burden on the prognosis, treatment and patients outcomes with a detrimental effect on their quality of life CACS reduces tolerance to therapy and increases postsurgical complications Overall, CACS accounts for up to 40% of all cancer-related deaths No evidence exists on the economic burden of CACS but cost-saving strategies of nutrition interventions for preventing CACS death Quality of life has been predominantly measured through the EORTC-QLQ-C30 and the FAACT Source: Tarricone et al. Impact of cancer-cachexia on the health-related quality of life and resource utilisation: a systematic review. Preliminary findings
14 Chemotherapy induced nausea and vomiting (CINV): open room to debate CINV is amongst the most unpleasant and distressing aspects of chemotherapy experienced by up to 60% of patients Inadequate control of emesis cause patients to delay or refuse potentially curative therapy Even one or two emetic episodes is associated with a significant deterioration in the quality of life, impairing social, physical and emotional functioning Currently anti-emetic drugs can cure up to 75-90% acute emesis Despite this, about 40-75% of cancer patients still suffer from delayed CINV, and it still remains the significant cause for chemotherapy related morbidity Source: Tarricone et al. Impact of chemotherapy-induced nausea and vomiting on costs and quality of life: a systematic review. Preliminary findings
15 Cancer Supportive Care: key to manage cancer care side effects Cancer supportive care (CSC) aims at improving patients and carers quality of life CSC can massively help reducing unnecessary costs CSC aims at providing accurate information for helping patients and their carers understand the side effects of cancer treatment and giving patients and their family the opportunity to participate in the decision making of the pathway of care More insight is however needed to assess CSC strategies and delivering patterns of care
16 Conclusive remarks: the way forward Compared to cancer, research in cancer care side effects is scant Side effects are too often mis-diagnosed, under-diagnosed, if not unrecognised till it is too late Scarce clinical evidence on different therapeutic strategies leads to lack of consensus on treatment modalities thus leaving the patients, carers, healthcare systems and societies bearing the full avoidable costs In times of resource constraints robust research is urgently needed to assess clinical outcomes of current and prospective strategies to prevent, or reduce side effects and compare them against economic costs
17 Conclusive remarks: the way forward Comprehensive burden of illness analysis need to be performed aimed at measuring the economic costs of side effects and who bears them. Comparative economic evaluation analysis (e.g. cost-effectiveness analysis) must be developed to estimate the differential costs and outcomes of several treatment modalities thus leading to universally agreed guidelines and patients access to cost-effective technologies: economic evidence in this area is worryingly scanty Quality of life must be assessed and compared against costs: Given the distress caused by side effects patient-reported outcomes need to be included in QoL evaluation Disease-specific QoL scales (e.g. EORTC-QLQ-C30, FAACT) must be compared to determine whether one is more sensitive to small changes in health-related quality of life (HRQoL) of cancer patients suffering from side effects Disease-specific HRQoL scales are however poorly informative if no utilities can be retrieved to make comparative assessment for policy-makers
18 Conclusive remarks: the way forward Cost-Effectiveness Analysis and Health Technology Assessment are common tools to decide the introduction in routine care of new technologies However to effectively support policy-makers in allocating scarce resources, health outcomes have to be measured and compared consistently across different disease areas The Quality-Adjusted-Life-Year (QALY) is the accepted health outcome by policymakers for comparative assessments and is estimated by deriving utilities from generic HRQoL tools such as the EuroQoL 5-Dimension (EQ-5D) and the Short Form 6- Dimension (SF-6D) Unless utilities can be retrieved by specific HRQoL tools in cancer care (e.g. FAACT), no comparative assessments on QALYs can be performed across different treatment modalities
19 Conclusive remarks: the way forward CERGAS and SDA Bocconi School of Management in collaboration with Helsinn Group are striving to fill the gaps in current evidence as to the economic burden of cancer treatment side effects; comparative economic evaluation analysis of different treatment modalities for sufferers of side effects; innovative clinical management patterns Given the multifaceted nature of the problem, clinical management of cancer care side effects must adopt a multimodality and multi-stakeholder approach Together with health professionals (i.e. oncologists, nurses), patients and carers have a role in managing side effects and with adequate knowledge they can ask appropriate assessments and interventions Mobile health has the great potential to connect patients, carers, and health professionals so to get early detection and intervention, less costs and higher quality of life
20 The future is here to come. Thank you.
No. prev. doc.: 8770/08 SAN 64 Subject: EMPLOYMENT, SOCIAL POLICY, HEALTH AND CONSUMER AFFAIRS COUNCIL MEETING ON 9 AND 10 JUNE 2008
COUNCIL OF THE EUROPEAN UNION Brussels, 22 May 2008 9636/08 SAN 87 NOTE from: Committee of Permanent Representatives (Part 1) to: Council No. prev. doc.: 8770/08 SAN 64 Subject: EMPLOYMENT, SOCIAL POLICY,
More informationNCDs POLICY BRIEF - INDIA
Age group Age group NCDs POLICY BRIEF - INDIA February 2011 The World Bank, South Asia Human Development, Health Nutrition, and Population NON-COMMUNICABLE DISEASES (NCDS) 1 INDIA S NEXT MAJOR HEALTH CHALLENGE
More informationCancer Rehabilitation: A Critical Component of Survivorship Care
Cancer Survivorship E-Learning Series for Primary Care Providers Cancer Rehabilitation: A Critical Component of Survivorship Care Julie K. Silver, MD Associate Professor Department of Physical Medicine
More informationHEALTH CARE COSTS 11
2 Health Care Costs Chronic health problems account for a substantial part of health care costs. Annually, three diseases, cardiovascular disease (including stroke), cancer, and diabetes, make up about
More informationECONOMIC COSTS OF PHYSICAL INACTIVITY
ECONOMIC COSTS OF PHYSICAL INACTIVITY This fact sheet highlights the prevalence and health-consequences of physical inactivity and summarises some of the key facts and figures on the economic costs of
More informationStrengthening of palliative care as a component of integrated treatment throughout the life course
EXECUTIVE BOARD EB134/28 134th session 20 December 2013 Provisional agenda item 9.4 Strengthening of palliative care as a component of integrated treatment throughout the life course Report by the Secretariat
More informationPROPOSAL GRADUATE CERTIFICATE ADVANCED PRACTICE ONCOLOGY SCHOOL OF NURSING TO BE OFFERED AT PURDUE UNIVERSITY WEST LAFAYETTE CAMPUS
Graduate Council Document 08-20b Approved by the Graduate Council November 20, 2008 PROPOSAL GRADUATE CERTIFICATE ADVANCED PRACTICE ONCOLOGY SCHOOL OF NURSING TO BE OFFERED AT PURDUE UNIVERSITY WEST LAFAYETTE
More informationKey Health Areas Mapped to Out of Hospital Programme Areas
1 Key Area (according to letter from David Nicholson) Reducing the number of years of life lost by the people of England from treatable conditions (e.g. including cancer, stroke, heart disease, respiratory
More informationSurvivorship Care Plans Guides for Living After Cancer Treatment
Survivorship Care Plans Guides for Living After Cancer Treatment Institute of Medicine Report 2005 Recommendations for meeting needs of cancer survivors Implement survivorship care plan Build bridges
More informationNHS outcomes framework and CCG outcomes indicators: Data availability table
NHS outcomes framework and CCG outcomes indicators: Data availability table December 2012 NHS OF objectives Preventing people from dying prematurely DOMAIN 1: preventing people from dying prematurely Potential
More informationJill Malcolm, Karen Moir
Evaluation of Fife- DICE: Type 2 diabetes insulin conversion Article points 1. Fife-DICE is an insulin conversion group education programme. 2. People with greater than 7.5% on maximum oral therapy are
More informationMeasuring quality along care pathways
Measuring quality along care pathways Sarah Jonas, Clinical Fellow, The King s Fund Veena Raleigh, Senior Fellow, The King s Fund Catherine Foot, Senior Fellow, The King s Fund James Mountford, Director
More informationChemotherapy Induced Nausea & Vomiting
Chemotherapy Induced Nausea & Vomiting A Nurse s Perspective Michael Flynn MSc, PG Cert, RGN Chemotherapy Nurse Consultant Guy s and St Thomas NHS Foundation Trust Guy s and St Thomas NHS Foundation Trust
More informationSaving costs, saving lives, improving healthcare in the UK - the economic case for early diagnosis
Saving costs, saving lives, improving healthcare in the UK - the economic case for early diagnosis Introduction Early detection and diagnosis of disease aims to prevent unnecessary pain, suffering and
More informationOncology Competency- Pain, Palliative Care, and Hospice Care
Pain, Palliative Care, and Hospice Care Palliative medicine relieves suffering and improves the quality of life for patients with advanced illness. The goal is achievement of the best quality of life for
More informationScreening for psychological distress in inoperable lung cancer patients: an evaluation of the Brief Distress Thermometer (BDT)
Screening for psychological distress in inoperable lung cancer patients: an evaluation of the Brief Distress Thermometer (BDT) K. Sharkey; A. Ugalde; M. Krishnasamy; K. Gough; D. Ball; S. Aranda; P. Schofield
More informationParkinson s Disease: Factsheet
Parkinson s Disease: Factsheet Tower Hamlets Joint Strategic Needs Assessment 2010-2011 Executive Summary Parkinson s disease (PD) is a progressive neuro-degenerative condition that affects a person s
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Schizophrenia: core interventions in the treatment and management of schizophrenia in primary and secondary care (update) 1.1
More informationThe Pharmacological Management of Cancer Pain in Adults. Clinical Audit Tool
The Pharmacological Management of Cancer Pain in Adults Clinical Audit Tool 2015 This clinical audit tool accompanies the Pharmacological Management of Cancer Pain in Adults NCEC National Clinical Guideline
More informationWhat is Palliative Care
What is Palliative Care Maine Quality Counts Portland Regional Forum Isabella N. Stumpf, DO Division Director, Palliative Medicine, Maine Medical Center Medical Director, Palliative Care, MaineHealth Disclosure
More informationPSA Screening for Prostate Cancer Information for Care Providers
All men should know they are having a PSA test and be informed of the implications prior to testing. This booklet was created to help primary care providers offer men information about the risks and benefits
More informationCancer research in the Midland Region the prostate and bowel cancer projects
Cancer research in the Midland Region the prostate and bowel cancer projects Ross Lawrenson Waikato Clinical School University of Auckland MoH/HRC Cancer Research agenda Lung cancer Palliative care Prostate
More informationPatient Electronic Alert to Key-worker System (PEAKS) Guidelines
Patient Electronic Alert to Key-worker System (PEAKS) Guidelines This procedural document supersedes: PAT/EC 4 v.1 Guidelines for Patient Electronic Alert to Key-worker systems (PEAKS). Did you print this
More informationService delivery interventions
Service delivery interventions S A S H A S H E P P E R D D E P A R T M E N T O F P U B L I C H E A L T H, U N I V E R S I T Y O F O X F O R D CO- C O O R D I N A T I N G E D I T O R C O C H R A N E E P
More informationSix Month Pilot Analysis: Improving Rehabilitation for Men with Prostate Cancer in North East London
Six Month Pilot Analysis: Improving Rehabilitation for Men with Prostate Cancer in North East London June 2015 Helen Whitney (Physiotherapist and Prostate Cancer Project Lead) Thufayel Islam (Prostate
More informationHospice and Palliative Care: Help Throughout Life s Journey. John P. Langlois MD CarePartners Hospice and Palliative Care
Hospice and Palliative Care: Help Throughout Life s Journey John P. Langlois MD CarePartners Hospice and Palliative Care Goals Define Palliative Care and Hospice. Describe and clarify the differences and
More informationCANCER PREVENTION AND CONTROL IN INDIA
CANCER PREVENTION AND CONTROL IN INDIA Cherian Varghese Non-communicable diseases including cancer are emerging as major public health problems in India. These diseases are lifestyle related, have a long
More informationThe benefits of prevention: healthy eating and active living
The benefits of prevention: healthy eating and active living A Summary of Findings By increasing the proportion of the NSW population who are a healthy weight by 2018 (so that one in two adults are of
More informationHow valuable is a cancer therapy? It depends on who you ask.
How valuable is a cancer therapy? It depends on who you ask. Comparing and contrasting the ESMO Magnitude of Clinical Benefit Scale with the ASCO Value Framework in Cancer Ram Subramanian Kevin Schorr
More informationCachexia and Nutrition in Advanced Cancer Patients: a Multidisciplinary Approach Chairs: M.S. Aapro, CH J. Herrstedt, DK F.
REPORT Cachexia and Nutrition in Advanced Cancer Patients: a Multidisciplinary Approach Chairs: M.S. Aapro, CH J. Herrstedt, DK F. Strasser, CH 13-14 March 2015 Barcelona, Spain The Conference Cachexia
More informationThe Impact of Palliative Care and Hospice Services in the Care of Patients with Advanced Stage Non-Small Cell Lung Cancer
The Impact of Palliative Care and Hospice Services in the Care of Patients with Advanced Stage Non-Small Cell Lung Cancer Richard C. Stephenson, MD Hospice & Palliative CareCenter Amy H. Hughes Forsyth
More informationGuidance on competencies for management of Cancer Pain in adults
Guidance on competencies for management of Cancer Pain in adults Endorsed by: Contents Introduction A: Core competencies for practitioners in Pain Medicine B: Competencies for practitioners in Pain Medicine
More informationNational Professional Development Framework for Cancer Nursing in New Zealand
National Professional Development Framework for Cancer Nursing in New Zealand Adapted from: National Cancer Education Project (EdCan). 2008. National Education Framework: Cancer nursing A national professional
More information(Resolutions, recommendations and opinions) RECOMMENDATIONS COUNCIL
3.7.2009 Official Journal of the European Union C 151/1 I (Resolutions, recommendations and opinions) RECOMMENDATIONS COUNCIL COUNCIL RECOMMENDATION of 9 June 2009 on patient safety, including the prevention
More informationESPEN Congress Florence 2008
ESPEN Congress Florence 2008 Nutritional consequences of cancer therapy Nutritional support and monitoring during chemoand radiotherapy M. Larsson (Sweden) Nutritional consequences of cancer therapy Nutritional
More informationSupportive Care For Patients With High-Grade Glioma (primary brain tumours) Dr Susan Catt & Professor Lesley Fallowfield
Supportive Care For Patients With High-Grade Glioma (primary brain tumours) Dr Susan Catt & Professor Lesley Fallowfield Partners Mr Giles Critchley Consultant Neurosurgeon Hurstwood Park Neurological
More informationAvastin in breast cancer: Summary of clinical data
Avastin in breast cancer: Summary of clinical data Worldwide, over one million people are diagnosed with breast cancer every year 1. It is the most frequently diagnosed cancer in women 1,2, and the leading
More informationDecision to Continue the Development of Tecemotide (L-BLP25) in Non-Small Cell Lung Cancer to be Announced
September 27, 2013 ONO PHARMACEUTICAL CO., LTD. Corporate Communications Phone: +81-6-6263-5670 Decision to Continue the Development of Tecemotide (L-BLP25) in Non-Small Cell Lung Cancer to be Announced
More information9/25/2012. Rehabilitation in Palliative Care: Restoration of patient to person. Rehabilitation in Palliative Care. Definitions:
Rehabilitation in Palliative Care: Restoration of patient to person Cathy Payne Doctoral Fellow All Ireland Institute of Hospice and Palliative Care Rehabilitation in Palliative Care Palliative care rehabilitation
More informationAvastin in breast cancer: Summary of clinical data
Avastin in breast cancer: Summary of clinical data Worldwide, over one million people are diagnosed with breast cancer every year 1. It is the most frequently diagnosed cancer in women 1,2, and the leading
More informationSPECIALTY CASE MANAGEMENT
SPECIALTY CASE MANAGEMENT Our Specialty Case Management programs boost ROI and empower members to make informed decisions and work with their physicians to better manage their health. KEPRO is Effectively
More informationPsoriasis, Incidence, Quality of Life, Psoriatic Arthritis, Prevalence
1.0 Abstract Title Prevalence and Incidence of Articular Symptoms and Signs Related to Psoriatic Arthritis in Patients with Psoriasis Severe or Moderate with Adalimumab Treatment (TOGETHER). Keywords Psoriasis,
More informationBreast Cancer in Young Women: Quality of Life and Survivorship
Breast Cancer in Young Women: Quality of Life and Survivorship Ann H. Partridge, MD, MPH Dana-Farber Cancer Institute Brigham and Women s Hospital Harvard Medical School Breast Cancer in Young Women is
More informationEuropean Dietitians in Oncology: The Future
European Dietitians in Oncology: The Future Carolina Bento Clare Shaw Julia Lobenwein 1 2 Oncology Workshop Introduction to the committee Clare Shaw (United Kingdom) Carolina Bento (Portugal) Julia Lobenwein
More informationRadiation Oncology Nursing Care. Helen Lusby Radiation Oncology Nurse BAROC 2012
Radiation Oncology Nursing Care Helen Lusby Radiation Oncology Nurse BAROC 2012 Definitions Radiation Therapy: Treatment of cancer using x- ray particles that cause ionisation within the cells. External
More informationMichigan Board of Nursing Guidelines for the Use of Controlled Substances for the Treatment of Pain
JENNIFER M. GRANHOLM GOVERNOR STATE OF MICHIGAN DEPARTMENT OF COMMUNITY HEALTH LANSING JANET OLSZEWSKI DIRECTOR Michigan Board of Nursing Guidelines for the Use of Controlled Substances for the Treatment
More informationMeasures for the Australian health system. Belinda Emms Health Care Safety and Quality Unit Australian Institute of Health and Welfare
Measures for the Australian health system Belinda Emms Health Care Safety and Quality Unit Australian Institute of Health and Welfare Two sets of indicators The National Safety and Quality Indicators Performance
More informationTheories on Metastasis: Innovative Thinking An Advocacy Perspective
Theories on Metastasis: Innovative Thinking An Advocacy Perspective Project LEAD Workshop NBCC Annual Advocacy Conference 2011 Musa Mayer AdvancedBC.org 1 The Big Question If we want to end death from
More informationFrequently Asked Questions Regarding At Home and Inpatient Hospice Care
Frequently Asked Questions Regarding At Home and Inpatient Hospice Care Contents Page: Topic Overview Assistance in Consideration Process Locations in Which VNA Provides Hospice Care Determination of Type
More informationNURSING RESEARCH IMPORTANT POINTS COMPONENTS COMPONENTS. Proposed timeline Consent/ protection of human
NURSING RESEARCH Implementation of a Chemotherapy-Induced Nausea and Vomiting Clinical Pathway for Moderate-high to Highly Emetogenic Chemotherapies A Nursing Research Project 2/01/2014 3/31/2015 PURPOSE:
More informationNovember 15, 2013. Ann Laramee MS ANP-BC ACNS-BC CHFN FletcherAllen.org
Advance Care Planning with Heart Failure: Results of a Primary Care Practitioners Needs Survey 5 th Annual Nursing Research and Evidence Based Practice Symposium November 15, 2013 Ann Laramee MS ANP-BC
More informationAn Integrated Approach to Lung Cancer in a Community Setting
An Integrated Approach to Lung Cancer in a Community Setting The multidisciplinary thoracic clinic at Erie Regional Cancer Center by Jan M. Rothman, MD, and Shelley D. KuBaney, RN, OCN 40 OI May June 2013
More informationRADIATION THERAPY MANAGEMENT PROGRAM CARECORE NATIONAL FREQUENTLY ASKED QUESTIONS FOR MVP PROVIDERS
RADIATION THERAPY MANAGEMENT PROGRAM CARECORE NATIONAL FREQUENTLY ASKED QUESTIONS FOR MVP PROVIDERS Evidence-Based Healthcare Solutions CARECORE NATIONAL. 400 BUCKWALTER PLACE BOULEVARD, BLUFFTON, SC 29910
More informationQuality standard Published: 11 June 2015 nice.org.uk/guidance/qs89
Pressure ulcers Quality standard Published: 11 June 2015 nice.org.uk/guidance/qs89 NICE 2015. All rights reserved. Contents Introduction... 6 Why this quality standard is needed... 6 How this quality standard
More informationButler Memorial Hospital Community Health Needs Assessment 2013
Butler Memorial Hospital Community Health Needs Assessment 2013 Butler County best represents the community that Butler Memorial Hospital serves. Butler Memorial Hospital (BMH) has conducted community
More informationDeterminants, Key Players and Possible Interventions
Major in Human Health, Nutrition and Environment, FS 2010 Public Health Concepts Determinants, Key Players and Possible Interventions David Fäh Aims Have an idea about which parameters can influence health
More informationSimplifying the measurement of co-morbidities and their influence on chemotherapy toxicity
Simplifying the measurement of co-morbidities and their influence on chemotherapy toxicity Dr Rajesh Sinha BSc MBBS MRCP, Clinical Research Fellow in Medical Oncology Brighton and Sussex University Hospitals
More informationBig Data and Oncology Care Quality Improvement in the United States
Big Data and Oncology Care Quality Improvement in the United States Peter P. Yu, MD, FACP, FASCO President, American Society of Clinical Oncology Director of Cancer Research, Palo Alto Medical Foundation
More informationLung Cancer: More than meets the eye
Lung Cancer Education Program November 23, 2013 Lung Cancer: More than meets the eye Shantanu Banerji MD, FRCPC Presenter Disclosure Faculty: Shantanu Banerji Relationships with commercial interests: Grants/Research
More informationCounting all the costs: the economic costs of comorbidities
Counting all the costs: the economic costs of comorbidities David McDaid and A-La Park LSE Health & Social Care, London School of Economics and Political Science E-mail: d.mcdaid@lse.ac.uk European Parliament
More informationEndpoints and quality of life
Endpoints and quality of life PFS, OS, quality of life and medico-economic assessment in oncology Isabelle Durand-Zaleski, Jérôme Garnier, Mira Pavlovic, and participants of roundtable n 3 Pascal Bilbault,
More informationWhat is the evidence on the economic impacts of integrated care?
What is the evidence on the economic impacts of integrated care? Ellen Nolte, Emma Pitchforth Integrated Care Summit 2014 The King s Fund, 14 October 2014 Background to the study Rising number of people
More informationHSE Transformation Programme. to enable people live healthier and more fulfilled lives. Easy Access-public confidence- staff pride
HSE Transformation Programme. to enable people live healthier and more fulfilled lives Easy Access-public confidence- staff pride The Health Service Executive 4.1 Chronic Illness Framework July 2008 1
More informationTHE FIRST STEPS INTO SURVIVORSHIP
10 th Annual Nebraska Cancer Summit THE FIRST STEPS INTO SURVIVORSHIP Sheri Sheriff, PT, DPT April 16, 2014 History of Cancer Wellness Program Need for Enhanced Survivorship Services Fragmented Resources
More informationNC General Statutes - Chapter 130A Article 7 1
Article 7. Chronic Disease. Part 1. Cancer. 130A-205. Administration of program; rules. (a) The Department shall establish and administer a program for the prevention and detection of cancer and the care
More informationInpatient Oncology Length of Stay and Hospital Costs: Implications for Rising Inpatient Expenditures
Inpatient Oncology Length of Stay and Hospital Costs: Implications for Rising Inpatient Expenditures Katie J. Suda, PharmD* Susannah E. Motl, PharmD John C. Kuth, PharmD * University of Tennessee, College
More informationSIOG Guidelines Update 2014 Prostate Cancer. Dr Helen Boyle Centre Léon Bérard SIOG meeting 25 October 2014,Lisbon
SIOG Guidelines Update 2014 Prostate Cancer Dr Helen Boyle Centre Léon Bérard SIOG meeting 25 October 2014,Lisbon Droz JP, Aapro M, Balducci L, Boyle H, Van den Broeck T, Cathcart P, Dickinson L, Efstathiou
More informationPalliative Care Role Delineation Framework
Director-General Palliative Care Role Delineation Framework Document Number GL2007_022 Publication date 26-Nov-2007 Functional Sub group Clinical/ Patient Services - Medical Treatment Clinical/ Patient
More informationThe cost of physical inactivity
The cost of physical inactivity October 2008 The cost of physical inactivity to the Australian economy is estimated to be $13.8 billion. It is estimated that 16,178 Australians die prematurely each year
More informationBristol Hospital Cancer Care Center 2015 Annual Report
Bristol Hospital Cancer Care Center 2015 Annual Report 2015 Annual Report Cancer Care Center At every point along the path, our team is there, keeping the focus on the most important team member - the
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Multiple Technology Appraisal
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Multiple Technology Appraisal Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional
More informationAn Introduction to PROSTATE CANCER
An Introduction to PROSTATE CANCER Being diagnosed with prostate cancer can be a life-altering experience. It requires making some very difficult decisions about treatments that can affect not only the
More informationObjectives. What is undernutrition? What is undernutrition? What does undernutrition look like?
Objectives Basics Jean-Pierre Habicht, MD, PhD Professor Division of Nutritional Sciences Cornell University Types and causes Determinants Consequences Global occurrence and progress Way forward What is
More informationIf you were diagnosed with cancer today, what would your chances of survival be?
Q.1 If you were diagnosed with cancer today, what would your chances of survival be? Ongoing medical research from the last two decades has seen the cancer survival rate increase by more than 40%. However
More informationWasteful spending in the U.S. health care. Strategies for Changing Members Behavior to Reduce Unnecessary Health Care Costs
Strategies for Changing Members Behavior to Reduce Unnecessary Health Care Costs by Christopher J. Mathews Wasteful spending in the U.S. health care system costs an estimated $750 billion to $1.2 trillion
More informationPRACTICE FRAMEWORK AND COMPETENCY STANDARDS FOR THE PROSTATE CANCER SPECIALIST NURSE
PRACTICE FRAMEWORK AND COMPETENCY STANDARDS FOR THE PROSTATE CANCER SPECIALIST NURSE MARCH 2013 MONOGRAPHS IN PROSTATE CANCER OUR VISION, MISSION AND VALUES Prostate Cancer Foundation of Australia (PCFA)
More informationGuidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes
Guidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes U.S. Department of Health and Human Services Food and Drug Administration Center
More informationONCOLOGY MANAGEMENT. Controlling Cancer-Related. Costs in Your Population. Intelligent Value. October 2012
ONCOLOGY MANAGEMENT Controlling Cancer-Related Costs in Your Population October 2012 ACCREDITED CASE MANAGEMENT DISEASE MANAGEMENT HEALTH UTILIZATION MANAGEMENT Intelligent Value Our URAC accredited care
More informationLessons from the Trenches: Transforming the Experience of People with Advanced Illness
Lessons from the Trenches: Transforming the Experience of People with Advanced Illness Lori Ann Attivissimo, MD, FACP, FAAHPM, HMDC Senior Medical Director of Hospice Care Network Medical Director for
More informationEconomic aspects of Spinal Cord Stimulation (SCS)
Economic aspects of Spinal Cord Stimulation (SCS) Burden of Chronic Pain Chronic pain affects one in five adults in Europe 1. Up to 10 per cent of chronic pain cases are neuropathic in origin. 2 Chronic
More informationFamily Caregiver s Guide to Hospice and Palliative Care
Family Caregiver Guide Family Caregiver s Guide to Hospice and Palliative Care Even though you have been through transitions before, this one may be harder. If you have been a family caregiver for a while,
More informationPrevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (AF) with one or more risk factors
News Release For use outside the US and UK only Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com Bayer s Xarelto Approved in the EU for the Prevention of Stroke in Patients
More informationAims of Nutritional Support in Oncology (Parenteral) Part 2
Aims of Nutritional Support in Oncology (Parenteral) Part 2 Rachel Barrett MSc, BSc (Hons) RD Principal Haematology-Oncology Dietitian Hong Kong Hospital Authority Commissioned Training November 20 th
More informationBreast Cancer Pathway
Breast Cancer Pathway Risk Stratified Follow Up Dr Dorothy Goddard, Associate Medical Director for Cancer Macmillan Consultant Medical Advisor Survivorship What is risk stratified follow up? Refers to
More informationCancer Survival - How Long Do People Survive?
A research briefing paper by Macmillan Cancer Support Introduction Key findings 3 People with cancer are surviving longer 4 Median survival time has seen dramatic improvement for some cancers 5 Median
More informationBACKGROUND MEDIA INFORMATION Fast facts about liver disease
BACKGROUND MEDIA INFORMATION Fast facts about liver disease Liver, or hepatic, disease comprises a wide range of complex conditions that affect the liver. Liver diseases are extremely costly in terms of
More information11. CANCER PAIN AND PALLIATION. Jennifer Reifel, M.D.
11. CANCER PAIN AND PALLIATION Jennifer Reifel, M.D. While supportive care was not one of the original clinical areas selected for the development of quality indicators, the Oncology and HIV Panel felt
More informationWhat is hospice care? Answering questions about hospice care
What is hospice care? Answering questions about hospice care Introduction If you, or someone close to you, have a life-limiting or terminal illness, you may have questions about the care you can get and
More informationMedical Oncology. Rotation Goals & Objectives for rotating residents. General Objectives THE UNIVERSITY OF BRITISH COLUMBIA
THE UNIVERSITY OF BRITISH COLUMBIA Department of Urologic Sciences Faculty of Medicine Gordon & Leslie Diamond Health Care Centre Level 6, 2775 Laurel Street Vancouver, BC, Canada V5Z 1M9 Tel: (604) 875-4301
More informationPalliative Medicine, Pain Management, and Hospice. Devon Neale, MD Assistant Professor Dept of Internal Medicine UNM School of Medicine
Palliative Medicine, Pain Management, and Hospice Devon Neale, MD Assistant Professor Dept of Internal Medicine UNM School of Medicine Pall-i- What??? Objectives: Provide information about Palliative Medicine
More informationSTRATEGIES FOR ASSESSING THE PATIENT-LEVEL ECONOMIC IMPACT OF CANCER DIAGNOSIS
Cumulative % Increase 5/20/2015 STRATEGIES FOR ASSESSING THE PATIENT-LEVEL ECONOMIC IMPACT OF CANCER DIAGNOSIS ISPOR 20 th Annual International Meeting -- Philadelphia, PA May 20 th 2015 Workshop Moderators:
More informationIncreased Support in the Continuum of Medical Care
Patient Information Guide Increased Support in the Continuum of Medical Care 8700 BEVERLY BLVD., LOS ANGELES, CALIFORNIA 90048 Cedars-Sinai Cancer Program CP0500 041503 Introduction There may come a time
More informationMichigan Guidelines for the Use of Controlled Substances for the Treatment of Pain
Michigan Guidelines for the Use of Controlled Substances for the Treatment of Pain Section I: Preamble The Michigan Boards of Medicine and Osteopathic Medicine & Surgery recognize that principles of quality
More informationQuality of Life Clinical Trials in Patients with Cancer
Quality of Life Clinical Trials in Patients with Cancer Danielle Noreika, MD Medical Director, Inpatient Palliative Services Division of Hematology, Oncology and Palliative Care Virginia Commonwealth University
More informationLearning Objectives. Establishing Goals of Care for the Chronically Critically Ill. What is Chronic Critical Illness?
Learning Objectives Establishing Goals of Care for the Chronically Critically Ill Cindy Drenning, CRNP Assistant Professor, Saint Francis University Define the chronically critically ill. Describe symptom
More informationFoundations of Oncology Nursing Practice
Foundations of Oncology Nursing Practice Course Syllabus Course Lead:, RN, MN, BScN, CON(C) Associate Faculty:, RN, CON(C) Last updated January 27, 2011 Course Description: This online course will introduce
More informationCalifornia HealthCare Foundation Education materials for patients with advanced cancer
California HealthCare Foundation Education materials for patients with advanced cancer The California HealthCare Foundation (CHCF) commissioned research to explore options around the development of patient
More informationPalliative Care Program Wentworth-Douglass Hospital
Palliative Care Program Wentworth-Douglass Hospital Patrick S. Alix, MD Director Michele Loos, RN, MS, CHPN Nurse Coordinator DEFINITION: PALLIATIVE CARE Interdisciplinary care that aims to relieve suffering
More informationWhat is a QALY? What is...? series. Second edition. Health economics. Supported by sanofi-aventis
...? series Supported by sanofi-aventis Second edition Health economics What is a QALY? Ceri Phillips BSc(Econ) MSc(Econ) PhD Professor of Health Economics, Swansea University A quality-adjusted life-year
More informationHospice and Palliative Medicine
Hospice and Palliative Medicine Maintenance of Certification Examination Blueprint Purpose of the exam The exam is designed to evaluate the knowledge, diagnostic reasoning, and clinical judgment skills
More information